O
Opto Circuits (India) Ltd
OPTOCIRCUI NSE
Opto Circuits (India) Ltd
HealthcareNSE: OPTOCIRCUI BSE: 532391 Healthcare Equipment & Supplies
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Opto Circuits (India) Ltd insights
29 extracted metrics + investor summaries across FY11–FY22.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
1- The company has delivered a poor sales growth of -65.4% over past five years.
Growth Rate
Revenue Growth
-97.00% →
Net Income Growth
651.00% →
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Results
| Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 24 | 27 | 23 | 8 | 23 | 8 | 8 | 1 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 14 | 14 | 13 | 8 | 15 | 10 | 6 | 3 | 1 | 2 | 1 | 1 | 14 |
| Operating Profit | 10 | 13 | 10 | 0 | 8 | -2 | 2 | -2 | -1 | -2 | -1 | -1 | -14 |
| OPM % | 43% | 48% | 45% | 2.8% | 34% | -22% | 22% | -349% | -1117% | -2244% | -1444% | -4350% | -69550% |
| Other Income | 1 | 0 | 0 | -856 | 1 | -350 | 0 | 2 | 0 | 0 | 0 | 0 | -142 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 8 | 10 | 8 | -856 | 9 | -352 | 1 | -1 | -2 | -2 | -1 | -1 | -155 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 8 | 10 | 8 | -856 | 9 | -352 | 1 | -1 | -2 | -2 | -1 | -1 | -155 |
| EPS in Rs | 0.29 | 0.34 | 0.28 | -28.48 | 0.29 | -11.72 | 0.05 | -0.02 | -0.06 | -0.07 | -0.04 | -0.03 | -5.17 |
Profit & Loss
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 603 | 670 | 699 | 263 | 146 | 77 | 50 | 63 | 105 | 63 | 8 | 0 |
| Expenses | 362 | 390 | 423 | 148 | 93 | 53 | 35 | 43 | 63 | 46 | 12 | 18 |
| Operating Profit | 242 | 279 | 276 | 115 | 53 | 23 | 15 | 20 | 42 | 17 | -4 | -17 |
| OPM % | 40% | 42% | 39% | 44% | 36% | 31% | 30% | 32% | 40% | 27% | -45% | -6924% |
| Other Income | 36 | 1 | -2 | -2 | -187 | 0 | -362 | 0 | 3 | -1,204 | 2 | -141 |
| Interest | 25 | 37 | 22 | 54 | 58 | 32 | 8 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 6 | 6 | 7 | 8 | 10 | 10 | 9 | 9 | 9 | 3 | 1 | 0 |
| PBT | 247 | 238 | 245 | 52 | -201 | -18 | -364 | 10 | 35 | -1,192 | -3 | -159 |
| Tax % | 1% | 1% | 2% | 18% | 0% | 3% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 244 | 235 | 241 | 42 | -202 | -18 | -364 | 10 | 35 | -1,192 | -3 | -159 |
| EPS in Rs | 10.09 | 9.69 | 9.95 | 1.74 | -8.32 | -0.74 | -15.02 | 0.35 | 1.16 | -39.63 | -0.09 | -5.28 |
| Div. Payout % | 34% | 31% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 186 | 242 | 242 | 242 | 242 | 242 | 242 | 288 | 301 | 301 | 301 | 301 |
| Reserves | 876 | 971 | 1,212 | 1,254 | 1,043 | 1,025 | 650 | 836 | 876 | -262 | -264 | -423 |
| Borrowings | 724 | 657 | 814 | 881 | 887 | 710 | 714 | 549 | 530 | 489 | 478 | 482 |
| Other Liabilities | 257 | 135 | 207 | 146 | 253 | 282 | 96 | 102 | 118 | 131 | 106 | 68 |
| Total Liabilities | 2,044 | 2,006 | 2,475 | 2,524 | 2,424 | 2,258 | 1,702 | 1,774 | 1,824 | 659 | 620 | 428 |
| Fixed Assets | 79 | 74 | 121 | 113 | 95 | 85 | 78 | 69 | 60 | 12 | 11 | 11 |
| CWIP | 1 | 1 | 1 | 1 | 0 | 102 | 102 | 157 | 158 | 0 | 0 | 0 |
| Investments | 1,114 | 382 | 382 | 382 | 382 | 382 | 382 | 437 | 447 | 202 | 202 | 20 |
| Other Assets | 849 | 1,549 | 1,971 | 2,028 | 1,948 | 1,689 | 1,141 | 1,112 | 1,159 | 445 | 407 | 397 |
| Total Assets | 2,044 | 2,006 | 2,475 | 2,524 | 2,424 | 2,258 | 1,702 | 1,774 | 1,824 | 659 | 620 | 428 |
Cash Flow
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 118 | -30 | -93 | -16 | 56 | 335 | 57 | 47 | 42 | 21 | -5 | -3 |
| Investing | -572 | 146 | -19 | 0 | 0 | -49 | -56 | -1 | -11 | 19 | 2 | -2 |
| Financing | 461 | -188 | 69 | 16 | -56 | -285 | -4 | -46 | -30 | -41 | 2 | 5 |
| Net Cash Flow | 7 | -72 | -43 | 0 | -1 | 1 | -2 | 0 | 0 | -1 | 0 | 0 |
| Free Cash Flow | 113 | -30 | -147 | -16 | 56 | 333 | 56 | 46 | 41 | 21 | -3 | -3 |
| CFO/OP | 50 | -9 | -32 | -5 | 106 | 1,427 | 382 | 231 | 101 | 127 | 124 | 19 |
Ratios
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 138 | 140 | 305 | 854 | 1,613 | 4 | 39 | 69 | 81 | 139 | 179 | 0 |
| Inventory Days | 265 | 266 | 336 | 1,341 | 1,943 | 3,660 | 2,459 | 394 | 237 | 475 | 1,149 | 470 |
| Days Payable | 6 | 12 | 52 | 114 | 670 | 1,827 | 173 | 292 | 289 | 792 | 4,188 | 775 |
| Cash Conversion Cycle | 397 | 395 | 589 | 2,082 | 2,887 | 1,837 | 2,324 | 171 | 29 | -179 | -2,860 | -305 |
| Working Capital Days | -88 | 307 | 495 | 1,396 | 2,023 | -1,806 | -4,111 | -2,519 | -1,474 | -2,753 | -21,186 | -6,71,060 |
| ROCE % | 19% | 15% | 13% | 5% | 2% | 1% | 0% | 1% | 2% | 1% | -1% | 6% |
Documents
1
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
9 Feb 2024 - Approval of resolution plans by CoC members. 9 Feb 2024 - Approval of resolution plans by CoC members.
2
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
7 Mar 2024 - Approval for extension of CIRP period by 30 days. 7 Mar 2024 - Approval for extension of CIRP period by 30 days.
3
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
29 Apr 2024 - Update on Corporate Insolvency Resolution Process. 29 Apr 2024 - Update on Corporate Insolvency Resolution Process.
4
Corporate Insolvency Resolution Process (CIRP)-Filing of Resolution plan with Tribunal
3 May 2024 - Approval of resolution plan under insolvency process. 3 May 2024 - Approval of resolution plan under insolvency process.
5
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
3 May 2024 - Non-submission of Corporate Governance Report due to insolvency. 3 May 2024 - Non-submission of Corporate Governance Report due to insolvency.
3
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors 29 Apr 2024
Company Update
4
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors 7 Mar 2024
Company Update
5
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors 9 Feb 2024
Company Update
Frequently Asked Questions about Opto Circuits (India) Ltd
What does Opto Circuits (India) Ltd do?
Incorporated in 1992, Opto Circuits (India) Ltd
is engaged in the manufacturing and trading of invasive and non-invasive medical equipment.
Where is Opto Circuits (India) Ltd (OPTOCIRCUI) listed?
Opto Circuits (India) Ltd is listed on the Indian stock exchanges. It is listed on NSE: OPTOCIRCUI and BSE: 532391. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Opto Circuits (India) Ltd belong to?
Opto Circuits (India) Ltd operates in the Healthcare sector within the Healthcare Equipment & Supplies industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Opto Circuits (India) Ltd on Tapetide?
On Tapetide, you can view Opto Circuits (India) Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1992, Opto Circuits (India) Ltd is engaged in the manufacturing and trading of invasive and non-invasive medical equipment.